Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Topical Analgesia with Lidocaine Plus Diclofenac Decreases Pain in Benign Anorectal Surgery: Randomized, Double-blind, and Controlled Clinical Trial.

Linares-Gil MJ, Valls J, Hereu-Boher P, Nebot FJ, De-Ramón B, Diaz-Munió E, Sanzol R, De-Oca J, Pérez-Lozano P, Suñé-Negre JM, García-Montoya E.

Clin Transl Gastroenterol. 2018 Nov 23;9(11):210. doi: 10.1038/s41424-018-0075-7.

2.

New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.

Azuara D, Aussó S, Rodriguez-Moranta F, Guardiola J, Sanjuan X, Lobaton T, Boadas J, Piqueras M, Monfort D, Guinó E, Moreno V, Capellá G, de Oca J.

Inflamm Bowel Dis. 2018 Nov 29;24(12):2555-2564. doi: 10.1093/ibd/izy255.

PMID:
30099509
3.

Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.

Alonso MH, Aussó S, Lopez-Doriga A, Cordero D, Guinó E, Solé X, Barenys M, de Oca J, Capella G, Salazar R, Sanz-Pamplona R, Moreno V.

Br J Cancer. 2017 Jul 25;117(3):421-431. doi: 10.1038/bjc.2017.208. Epub 2017 Jul 6.

4.

Discovery and validation of new potential biomarkers for early detection of colon cancer.

Solé X, Crous-Bou M, Cordero D, Olivares D, Guinó E, Sanz-Pamplona R, Rodriguez-Moranta F, Sanjuan X, de Oca J, Salazar R, Moreno V.

PLoS One. 2014 Sep 12;9(9):e106748. doi: 10.1371/journal.pone.0106748. eCollection 2014.

5.

Relationship between methylation and colonic inflammation in inflammatory bowel disease.

Lobatón T, Azuara D, Rodríguez-Moranta F, Loayza C, Sanjuan X, de Oca J, Fernández-Robles A, Guardiola J, Capellá G.

World J Gastroenterol. 2014 Aug 14;20(30):10591-8. doi: 10.3748/wjg.v20.i30.10591.

6.

Anti-inflammatory effects of ischemic preconditioning on rat small bowel allografts.

Camprodon RA, Bowles MJ, Pockley AG, de Oca J.

Transplant Proc. 2014 Jul-Aug;46(6):2146-9. doi: 10.1016/j.transproceed.2014.06.038.

PMID:
25131127
7.

Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.

Sanz-Pamplona R, Berenguer A, Cordero D, Molleví DG, Crous-Bou M, Sole X, Paré-Brunet L, Guino E, Salazar R, Santos C, de Oca J, Sanjuan X, Rodriguez-Moranta F, Moreno V.

Mol Cancer. 2014 Mar 5;13:46. doi: 10.1186/1476-4598-13-46.

8.

Comparison of the long-term outcome of two therapeutic strategies for the management of abdominal abscess complicating Crohn's disease: percutaneous drainage or immediate surgical treatment.

Lobatón T, Guardiola J, Rodriguez-Moranta F, Millán-Scheiding M, Peñalva M, De Oca J, Biondo S.

Colorectal Dis. 2013;15(10):1267-72. doi: 10.1111/codi.12419.

PMID:
24102970
9.

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.

Carmona FJ, Azuara D, Berenguer-Llergo A, Fernández AF, Biondo S, de Oca J, Rodriguez-Moranta F, Salazar R, Villanueva A, Fraga MF, Guardiola J, Capellá G, Esteller M, Moreno V.

Cancer Prev Res (Phila). 2013 Jul;6(7):656-65. doi: 10.1158/1940-6207.CAPR-12-0501. Epub 2013 May 21.

10.

Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer.

Azuara D, Ginesta MM, Gausachs M, Rodriguez-Moranta F, Fabregat J, Busquets J, Pelaez N, Boadas J, Galter S, Moreno V, Costa J, de Oca J, Capellá G.

Clin Chem. 2012 Sep;58(9):1332-41. doi: 10.1373/clinchem.2012.186577. Epub 2012 Jun 27.

11.

Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.

Azuara D, Rodriguez-Moranta F, de Oca J, Sanjuan X, Guardiola J, Lobaton T, Wang A, Boadas J, Piqueras M, Monfort D, Galter S, Esteller M, Moreno V, Capellá G.

Inflamm Bowel Dis. 2013 Jan;19(1):165-73. doi: 10.1002/ibd.22994.

PMID:
22532293
12.

Long-term results of surgery plus fibrin sealant for anal fistula.

de Oca J, Millán M, Jiménez A, Golda T, Biondo S.

Colorectal Dis. 2012 Jan;14(1):e12-5. doi: 10.1111/j.1463-1318.2011.02747.x.

PMID:
21819522
13.

Novel methylation panel for the early detection of colorectal tumors in stool DNA.

Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, Biondo S, Blanco I, Peinado MA, Moreno V, Esteller M, Capellá G.

Clin Colorectal Cancer. 2010 Jul;9(3):168-76. doi: 10.3816/CCC.2010.n.023.

PMID:
20643622
14.

Time course of necrosis/apoptosis and neovascularization during experimental gastric conditioning.

Lamas S, Azuara D, de Oca J, Sans M, Farran L, Alba E, Escalante E, Rafecas A.

Dis Esophagus. 2008;21(4):370-6. doi: 10.1111/j.1442-2050.2007.00772.x.

PMID:
18477261
15.

Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer.

de Oca J, Azuara D, Sanchez-Santos R, Navarro M, Capella G, Moreno V, Sola A, Hotter G, Biondo S, Osorio A, Martí-Ragué J, Rafecas A.

Int J Colorectal Dis. 2008 Jan;23(1):21-7. Epub 2007 Sep 4.

PMID:
17805550
16.

[Long-term results of emergency surgery for colon cancer compared with elective surgery].

Biondo S, Kreisler E, Millan M, Martí-Ragué J, Fraccalvieri D, Golda T, De Oca J, Osorio A, Fradera R, Salazar R, Rodriguez-Moranta F, Sanjuán X.

Cir Esp. 2007 Aug;82(2):89-98. Spanish.

17.

Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk.

Landi S, Bottari F, Gemignani F, Gioia-Patricola L, Guino E, Osorio A, de Oca J, Capella G, Canzian F, Moreno V; Bellvitge Colorectal Cancer Study Group.

Eur J Cancer. 2007 Mar;43(4):762-8. Epub 2007 Jan 26.

PMID:
17258448
18.

Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.

Dotor E, Cuatrecases M, Martínez-Iniesta M, Navarro M, Vilardell F, Guinó E, Pareja L, Figueras A, Molleví DG, Serrano T, de Oca J, Peinado MA, Moreno V, Germà JR, Capellá G, Villanueva A.

J Clin Oncol. 2006 Apr 1;24(10):1603-11.

PMID:
16575011
19.

[Translational research in surgery].

de Oca J.

Cir Esp. 2005 Sep;78(3):135-7. Spanish. No abstract available.

20.

[Current status of follow-up of the upper digestive tract in familial adenomatous polyposis].

Parés D, García-Ruiz A, Biondo S, Blanco I, Llort G, Arriol E, de Oca J, del Río C, Osorio A, Navarro M, Martí-Ragué J, Jaurrieta E.

Gastroenterol Hepatol. 2006 Jan;29(1):15-20. Review. Spanish.

PMID:
16393625
21.

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.

Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, Navarro M, de Oca J, Capellà G, Canzian F; Bellvitge Colorectal Cancer Study Group.

Pharmacogenet Genomics. 2005 Aug;15(8):535-46.

PMID:
16006997
22.

Apoptosis inhibition during preservation by fructose-1,6-diphosphate and theophylline in rat intestinal transplantation.

Genescà M, Sola A, Azuara D, De Oca J, Hotter G.

Crit Care Med. 2005 Apr;33(4):827-34.

PMID:
15818112
23.

Large bowel obstruction: predictive factors for postoperative mortality.

Biondo S, Parés D, Frago R, Martí-Ragué J, Kreisler E, De Oca J, Jaurrieta E.

Dis Colon Rectum. 2004 Nov;47(11):1889-97.

PMID:
15622582
24.
25.

[Survival and recurrence in the multidisciplinary approach of colorectal cancer].

Martí-Ragué J, Parés D, Biondo S, Navarro M, Figueras J, de Oca J, Pareja L, Cambray M, del Río C, Osorio A, Novell V, Jaurrieta E.

Med Clin (Barc). 2004 Sep 11;123(8):291-6. Spanish.

PMID:
15373975
26.

Protective effects of exogenous fructose-1,6-biphosphate during small bowel transplantation in rats.

Sola A, De Oca J, Alfaro V, Xaus C, Jaurrieta E, Hotter G.

Surgery. 2004 May;135(5):518-26.

PMID:
15118589
27.

Long-term urinary dysfunction after rectal cancer surgery.

Del Río C, Sánchez-Santos R, Oreja V, De Oca J, Biondo S, Parés D, Osorio A, Martí-Ragué J, Jaurrieta E.

Colorectal Dis. 2004 May;6(3):198-202.

PMID:
15109387
28.

Administration of nitric oxide with caspase inhibitors minimizes bacterial translocation in experimental intestinal transplantation.

Azuara D, Sola A, Hotter G, Calatayud L, Jaurrieta E, de Oca J.

Transplantation. 2004 Jan 27;77(2):177-83.

PMID:
14742977
29.

Immunodulation with tacrolimus (FK506): results of a prospective, open-label, non-controlled trial in patients with inflammatory bowel disease.

de Oca J, Vilar L, Castellote J, Sánchez Santos R, Parés D, Biondo S, Osorio A, del Rio C, Jaurrieta E, Martí Ragué J.

Rev Esp Enferm Dig. 2003 Jul;95(7):465-70, 459-64. English, Spanish.

PMID:
14515846
30.

Role of nitric oxide in apoptosis and cell necrosis for intestinal transplantation.

Azuara D, Sola A, Hotter G, Calatayud L, Jaurrieta E, de Oca J.

Transplant Proc. 2003 Aug;35(5):1931-2.

PMID:
12962853
31.

Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.

Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J, Capella G, Canzian F; Bellvitge Colorectal Cancer Study Group.

Cancer Res. 2003 Jul 1;63(13):3560-6.

32.

Long-term results of ileal pouch-anal anastomosis in Crohn's disease.

de Oca J, Sánchez-Santos R, Ragué JM, Biondo S, Parés D, Osorio A, del Rio C, Jaurrieta E.

Inflamm Bowel Dis. 2003 May;9(3):171-5.

PMID:
12792222
33.

Emergency operations for nondiverticular perforation of the left colon.

Biondo S, Parés D, Martí Ragué J, De Oca J, Toral D, Borobia FG, Jaurrieta E.

Am J Surg. 2002 Mar;183(3):256-60.

PMID:
11943122
34.

Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation.

Sola A, De Oca J, González R, Prats N, Roselló-Catafau J, Gelpí E, Jaurrieta E, Hotter G.

Ann Surg. 2001 Jul;234(1):98-106.

35.

Prognostic factors for mortality in left colonic peritonitis: a new scoring system.

Biondo S, Ramos E, Deiros M, Ragué JM, De Oca J, Moreno P, Farran L, Jaurrieta E.

J Am Coll Surg. 2000 Dec;191(6):635-42.

PMID:
11129812
36.

Liver xenotransplantation: changes in lipid and lipoprotein concentration after long-term graft survival.

Molleví DG, Jaurrieta E, Ribas Y, Hurtado I, Serrano T, Gómez N, de Oca J, Fiol C, Figueras J.

J Hepatol. 2000 Apr;32(4):655-60.

PMID:
10782915
37.

Alterations of lipoprotein metabolism in a concordant model of liver xenotransplantation.

Molleví DG, Ribas Y, Jaurrieta E, Gómez N, de Oca J, Fiol C, Figueras J.

Transplant Proc. 1999 Sep;31(6):2620-1. No abstract available.

PMID:
10500746
38.

Role of nitric oxide in preconditioning for intestinal transplantation.

de Oca J, Hotter G, Sola A, González R, Rafecas A, Roselló J, Jaurrieta E.

Transplant Proc. 1999 Sep;31(6):2573. No abstract available.

PMID:
10500724
39.

Protective effects of lazaroid U74389G on intestinal graft after heterotopic small bowel transplantation in rats.

de Oca J, Cuadrado S, Vallet J, Benasco C, Martín E, Ardanuy C, Closa D, Hotter G, Jaurrieta E.

J Surg Res. 1998 Feb 15;75(1):18-23.

PMID:
9614851
40.

21-Aminosteroid U-74389G (lazaroid) inhibits bacterial translocation after small bowel transplantation in rats.

de Oca J, Vallet J, Cuadrado S, Bettónica C, Martín E, González R, Ardanuy C.

Transplant Proc. 1997 May;29(3):1803. No abstract available.

PMID:
9142278
41.

Effect of oral supplementation of ornithine-alpha-ketoglutarate on the intestinal barrier after orthotopic small bowel transplantation.

de Oca J, Bettonica C, Cuadrado S, Vallet J, Martín E, Garcia A, Montañés T, Jaurrieta E.

Transplantation. 1997 Mar 15;63(5):636-9.

PMID:
9075830
42.

Double-barreled wet colostomy: a safe and simple method after pelvic exenteration.

Osorio Gullón A, de Oca J, Lopéz Costea MA, Virgili J, Ramos E, del Rio C, Martí Ragué J.

Int J Colorectal Dis. 1997;12(1):37-41.

PMID:
9112149
43.

Protective effects of ornithin-alpha-ketoglutarate supplementation on intestinal mucosa after orthotopic small bowel transplantation.

de Oca J, Bettonica C, Cuadrado S, Vallet J, Montañés T, Martín E.

Transplant Proc. 1996 Oct;28(5):2657. No abstract available.

PMID:
8907996
44.

[Options in the surgical treatment of diffuse cavernous hemangioma of the rectum].

Castellví J, Pares D, Ramos E, Serrano T, de Oca J, Martí-Ragué J.

Rev Esp Enferm Dig. 1996 Aug;88(8):566-8. Spanish.

PMID:
8962763
45.

Nutrition after small bowel transplantation: effects of oral supplementation with ornithine-alpha-ketoglutarate.

Bettonica C, de Oca J, Vallet J, Montañés T, Ardanuy C, Martí Ragué J, Cuadrado S, Fiol C.

Transplant Proc. 1995 Aug;27(4):2407-8. No abstract available.

PMID:
7652854
46.

Influence of liquid preservation on lipid peroxidation and bacterial permeability after small bowel transplantation.

De Oca J, Vallet J, Bettonica C, García A, Montañés T, Castells A, Cuadrado S, Mercadal M, Fiol C.

Transplant Proc. 1995 Aug;27(4):2382-3. No abstract available.

PMID:
7652846
47.

[Bacterial translocation from the nutritional perspective].

de Oca J.

Nutr Hosp. 1994 Jan-Feb;9(1):2-11. Review. Spanish.

PMID:
8172982
48.

Selective bowel decontamination, nutritional therapy and bacterial translocation after burn injury.

De Oca J, Millat E, Dominguez MA, Aldeano A, Martin R.

Clin Nutr. 1993 Dec;12(6):355-9.

PMID:
16843338
49.

[Nutritional status and heart valve surgery: response to surgical aggression].

Herreros J, Cato J, De Oca J, Castells E.

Ann Ital Chir. 1992 Mar-Apr;63(2):155-60; discussion 161. Italian.

PMID:
1503372
50.

Supplemental Content

Loading ...
Support Center